APA (7th ed.) Citation

T, C., & M, L. (2026). Real-world safety assessment of burosumab: A pharmacovigilance study utilizing the FDA adverse event reporting system. Orphanet journal of rare diseases, 21(1), . https://doi.org/10.1186/s13023-026-04267-9

Chicago Style (17th ed.) Citation

T, Chen, and Liang M. "Real-world Safety Assessment of Burosumab: A Pharmacovigilance Study Utilizing the FDA Adverse Event Reporting System." Orphanet Journal of Rare Diseases 21, no. 1 (2026). https://doi.org/10.1186/s13023-026-04267-9.

MLA (9th ed.) Citation

T, Chen, and Liang M. "Real-world Safety Assessment of Burosumab: A Pharmacovigilance Study Utilizing the FDA Adverse Event Reporting System." Orphanet Journal of Rare Diseases, vol. 21, no. 1, 2026, https://doi.org/10.1186/s13023-026-04267-9.